Alternative to the Digitalis Glycosides for Heart Failure

Overview

Journal Br Med J (Clin Res Ed)

Specialty General Medicine

Date 1985 May 18

PMID 3922555

Authors

P Wilmshurst

Affiliations

Soon will be listed here.

References

Marcus M, Skelton C, Grauer L, Epstein S . Effects of theophylline on myocardial mechanics. Am J Physiol. 1972; 222(6):1361-5. DOI: 10.1152/ajplegacy.1972.222.6.1361. View

Firth B, Ratner A, Grassman E, Winniford M, NICOD P, Hillis L . Assessment of the inotropic and vasodilator effects of amrinone versus isoproterenol. Am J Cardiol. 1984; 54(10):1331-6. DOI: 10.1016/s0002-9149(84)80092-2. View

Meisheri K, Palmer R, van Breemen C . The effects of amrinone on contractility, Ca2+ uptake and cAMP in smooth muscle. Eur J Pharmacol. 1980; 61(2):159-65. DOI: 10.1016/0014-2999(80)90158-2. View

Levine S, Jacoby M, Satriano J, Schlondorff D . The effects of amrinone on transport and cyclic AMP metabolism in toad urinary bladder. J Pharmacol Exp Ther. 1981; 216(2):220-4. View

Honerjager P, Schafer-Korting M, Reiter M . Involvement of cyclic AMP in the direct inotropic action of amrinone. Biochemical and functional evidence. Naunyn Schmiedebergs Arch Pharmacol. 1981; 318(2):112-20. DOI: 10.1007/BF00508835. View

Endoh M, Yamashita S, Taira N . Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle. J Pharmacol Exp Ther. 1982; 221(3):775-83. View

Kinney E, Carlin B, Ballard J, Burks J, Hallahan W, Zelis R . Clinical experience with amrinone in patients with advanced congestive heart failure. J Clin Pharmacol. 1982; 22(10):433-40. DOI: 10.1002/j.1552-4604.1982.tb02632.x. View

Wilmshurst P, Thompson D, Jenkins B, Coltart D, Webb-Peploe M . Haemodynamic effects of intravenous amrinone in patients with impaired left ventricular function. Br Heart J. 1983; 49(1):77-82. PMC: 485213. DOI: 10.1136/hrt.49.1.77. View

Opie L . Principles of therapy for congestive heart failure. Eur Heart J. 1983; 4 Suppl A:199-208. DOI: 10.1093/eurheartj/4.suppl_a.199. View

10.

Gaide M, Fitterman W, Wiggins J, Myerburg R, Cameron J, BASSETT A . Amrinone relaxes potassium-induced contracture of failing right ventricular muscle of cats. J Cardiovasc Pharmacol. 1983; 5(2):335-40. DOI: 10.1097/00005344-198303000-00028. View

11.

Hermiller J, Leithe M, Magorien R, Unverferth D, Leier C . Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug. J Pharmacol Exp Ther. 1984; 228(2):319-26. View

12.

Wilmshurst P, Walker J, Fry C, MOUNSEY J, Twort C, Williams B . Inotropic and vasodilator effects of amrinone on isolated human tissue. Cardiovasc Res. 1984; 18(5):302-9. DOI: 10.1093/cvr/18.5.302. View

13.

Scholz H . Inotropic drugs and their mechanisms of action. J Am Coll Cardiol. 1984; 4(2):389-97. DOI: 10.1016/s0735-1097(84)80231-4. View

14.

DiBianco R, Shabetai R, Silverman B, Leier C, Benotti J . Oral amrinone for the treatment of chronic congestive heart failure: results of a multicenter randomized double-blind and placebo-controlled withdrawal study. J Am Coll Cardiol. 1984; 4(5):855-66. DOI: 10.1016/s0735-1097(84)80044-3. View

15.

Packer M, Medina N, Yushak M . Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure. Circulation. 1984; 70(6):1038-47. DOI: 10.1161/01.cir.70.6.1038. View

16.

Benotti J, Grossman W, Braunwald E, DAVOLOS D, ALOUSI A . Hemodynamic assessment of amrinone. A new inotropic agent. N Engl J Med. 1978; 299(25):1373-7. DOI: 10.1056/NEJM197812212992501. View